Race/ethnicity and validity of self-reported pneumococcal vaccination by Gordon, Nancy P et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Public Health
Open Access Research article
Race/ethnicity and validity of self-reported pneumococcal 
vaccination
Nancy P Gordon*1, Pascale M Wortley2, James A Singleton2, Teresa Y Lin1 
and Barbara H Bardenheier2
Address: 1Kaiser Permanente Division of Research, Oakland, CA, USA and 2Immunization Services Division, National Center for Immunizations 
and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Email: Nancy P Gordon* - nancy.gordon@kp.org; Pascale M Wortley - PWortley@cdc.gov; James A Singleton - JSingleton@cdc.gov; 
Teresa Y Lin - teresa.y.lin@dor.kaiser.org; Barbara H Bardenheier - BBardenheier@cdc.gov
* Corresponding author    
Abstract
Background: National and state surveys show large disparities in pneumococcal vaccination
status among Whites, Blacks and Latinos aged ≥ 65. The purpose of this study is to determine
whether there is any difference in the validity of self-report for pneumococcal vaccination by race/
ethnicity that might contribute to the substantial disparities observed in population-level coverage
estimates.
Methods: Self-reported vaccination status was compared with medical record documentation for
samples of White, Black, and Latino members of a large health plan to examine whether differences
in validity of self-report contribute to observed disparities.
Results: Sensitivity was significantly lower for Blacks (0.849, 95% CI 0.818–0.876) and Latinos
(0.869, 95% CI 0.847–0.889) than for Whites (0.931 95% CI 0.918–0.942). Specificity was
somewhat higher for Blacks than for Latinos and Whites, but the differences were not statistically
significant. Coverage for Whites, Blacks and Latinos, respectively, was 84.3%, 73.5%, and 82.3%
based on self-report, but 74.8%, 71.9%, and 84.2% based on medical records.
Conclusion: The results of this study suggest that differential self-report error, i.e., summative
effect of over-reporting and under-reporting within a race-ethnic group, may contribute to the size
and direction of race-ethnic disparities in pneumococcal vaccination observed in surveys.
Background
Invasive pneumococcal disease accounted for approxi-
mately 3,400 deaths per year among persons aged 65 and
over during 1990–1999 [1]. CDC's Advisory Committee
on Immunization Practices (ACIP) recommends a single
dose of pneumococcal polysaccharide vaccine for all peo-
ple 65 years and older [2]. Healthy People 2010 Objec-
tives call for ≥ 90% of adults aged ≥ 65 to have had a
pneumococcal vaccination [3], and pneumococcal vacci-
nation of adults in this age group has been made a per-
formance measure for the 2004 Health Plan Employer
Data and Information Set (HEDIS) sponsored by the
National Committee for Quality Assurance (NCQA).
National surveys have found that while pneumococcal
vaccination coverage has significantly increased over the
years, vaccination rates of Black and Hispanic/Latino sen-
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iors are 17 to 30 percentage points lower than for Whites
[4-6]. These differences persist even among seniors with
higher likelihood of receiving preventive services, i.e.,
those with health insurance [5,6] and with at least some
college education [7]. The reasons for the disparities are
yet to be well understood and are probably multifactorial
[8,9].
Estimates of pneumococcal vaccination coverage are
based on self-reported information from state (e.g.,
Behavioral Risk Factor Surveillance System (BRFSS)) and
national (e.g., National Health Interview Survey (NHIS))
surveys, or at a more local level, from health plan member
surveys conducted for quality of care reporting purposes.
Recall for pneumococcal vaccination has been shown to
be less accurate than for influenza vaccination [10-12]
presumably at least in part because the event may have
occurred in the more distant past. In addition, because
awareness about the vaccine is less [8], recall of its receipt
may thus be less. The purpose of this study is to determine
whether there is any difference between Blacks, Hispanics,
and Whites in the validity of self-report for pneumococcal
vaccination that might contribute to the substantial dis-
parities observed in population-level coverage estimates.
The Kaiser Permanente Medical Program in Northern Cal-
ifornia offered the opportunity to conduct a study where
self-report of vaccination could be compared to medical
records in a diverse population of over 380,000 members
aged 65 and over. This survey and its use to conduct this
validation study was approved by the Kaiser Foundation
Research Institute Institutional Review Board.
Methods
Source of self-reported vaccination status
Every three years since 1993, Kaiser Permanente in North-
ern California has conducted an adult Member Health
Survey, a self-administered mailed survey which covers
demographic characteristics, health status, health condi-
tions, behavioral health risks, and receipt of preventive
and patient education services. The overall response rate
among adults aged ≥ 65 was 74% for both the 1999 and
2002 surveys, yielding approximately 7,100 respondents
each year. Combining 1999 and 2002 respondents
yielded 11,182 men and women aged 66–85 who self-
identified as White/Euro-American (White), African
American/Black (Black), or Hispanic/Latino (Latino).
Respondents were asked if they ever had a pneumonia
shot, with answer options of "Yes, at Kaiser," "Yes, but not
at Kaiser," "No," or "Don't Know/Don't remember." Esti-
mates of pneumococcal vaccination coverage based on
data from the 2002 survey weighted to the adult member-
ship at the time of the survey are shown in Table 1.
Study population
Subjects for this study were selected from a pool of current
and former health plan members aged 66–85 who had
responded to either the 1999 or 2002 Kaiser Permanente
Member Health Survey, were able to comprehend English
(since the questionnaires were only available in English),
self-identified as White, Black, or Latino (but not more
than one race-ethnicity) on the questionnaire, and had
been continuous members of the Health Plan from within
3 months after turning age 65 through the date the survey
questionnaire was returned. From this eligible pool of sur-
vey respondents, for each of the 3 race-ethnic groups, sam-
ples of up to 100 men and 100 women who had indicated
receiving a pneumococcal vaccination (hereafter, pneu-
movax) from the Health Plan (i.e., not from another
source), and up to 100 men and 100 women who had
indicated never having had this vaccination were selected.
The final study sample consisted of 400 nonHispanic
Whites (hereafter referred to as Whites), 300 nonHispanic
Blacks (hereafter referred to as Blacks), and 261 Hispan-
ics/Latinos (hereafter referred to as Latinos), most of
whom were of Mexican or Central American descent). All
eligible Blacks and Latinos were included, but Whites
were randomly sampled as follows: Pneumovax Yes: 100/
2419 men and 100/2724 women; Pneumovax No: 100/
472 men 100/472 and 100/486 women.
Health plan medical record documentation of vaccination 
status
Health Plan medical records for each of the 961 individu-
als in the final sample were searched for a retrospective
interval of up to 10 years prior to the age of 65 (depending
on the age at which the individual had joined the health
plan) through the date the self-reported information was
received to determine whether there was any record that
the individual had received a pneumovax from the Health
Plan or from outside the Health Plan (as reported in a
chart note). First searched was the Health Plan's immuni-
zation tracking database (KITS), which by January 1995
captured the dates of all health plan-administered pneu-
mococcal vaccinations. Subjects with a pneumovax date
in the immunization tracking database that came after the
date the questionnaire was completed were assumed to be
unvaccinated prior to the provision of the self-report. For
the 137 out of 961 study subjects without a pneumovax
date in the immunization tracking database, comprehen-
sive reviews of all hardcopy medical charts from every out-
patient clinic and hospital where the individual received
care during their retrospective study interval were com-
pleted, irrespective of whether they had reported a pneu-
movax or not.
Data analysis
The validity of self-report compared with Health Plan
medical records (HPMR) was assessed for each race/ethnicBMC Public Health 2008, 8:227 http://www.biomedcentral.com/1471-2458/8/227
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group by calculating rates of sensitivity, specificity, false
positives, and false negatives, assuming the HPMR to be
the "gold standard" of accuracy. Sensitivity ("true posi-
tives") is the proportion of those with a pneumovax doc-
umented in the HPMR that reported having had a
pneumovax. Specificity ("true negatives") is the propor-
tion of those with no pneumovax documented in the
HPMR who reported never having had a pneumovax. The
proportions under- and over-reporting vaccination corre-
spond to 1-sensitivity and 1-specificity, respectively. Posi-
tive Predictive Value (PPV), the complement of the false
positive rate, is the proportion of those who reported a
pneumovax who had this confirmed by the HPMR. Nega-
tive Predictive Value (NPV), the complement of the false
negative value (FNV), represents the proportion of those
who reported no pneumovax who had this confirmed by
the HPMR. These analyses were conducted using
SUDAAN [13]. Kappa statistics were also calculated to
determine the degree of agreement. Strength of agreement
is considered almost perfect for kappa values ≥ 0.81; very
good for values of .61 to .80; moderate for values of .41 to
.60; fair for values of .21 to .40; and poor for values =.20
[14].
Logistic regression models were used to test whether sen-
sitivity and specificity differed by race/ethnicity after con-
trolling for (1) age and gender and (2) age, gender and
education, and (3) age and education in separate models
for men and women. The modeling of sensitivity was
restricted to people whose HPMR documented receipt of
a pneumovax, and the modeling of specificity was
restricted to people with no HPMR documentation of a
pneumovax. The covariates were represented by sets of
indicator variables: gender, female vs. male; age, 70–74,
75–79, 80–85 vs. 66–74; and education, < 12th grade,
some post-high school, college graduate vs. high school
Table 1: Estimated Percentages of White, Black, and Latino Health Plan Members Aged 66–85 Who Ever Had a Pneumococcal 
Vaccination, 2002a
Group % Pneumococcal Vaccination, Excluding 
Don't Know and Missing Data from 
Denominator
% Pneumococcal Vaccination, Including 
Don't Know and Missing Data in 
Denominator
% with Unknown 
Pneumococcal Vaccination 
Status
% (95% CI) (Sample N) % (95% CI) (Sample N) % (95% CI)
ALL
White 83.7%
(82.5% – 85.0%)
(N = 4573)
77.6%
(76.2% – 78.9%)
(N = 4945)
7.4%
(6.5% – 8.2%)
Black 78.2%
(72.6% – 83.8%)
(N= 273)
67.8%
(61.8% – 73.7%)
(N = 316)
13.3%
(9.0% – 17.7%)
Latino 78.5%
(73.5% – 83.5%)
(N = 351)
69.5%
(64.3% – 74.7%)
(N = 400)
11.5%
(8.0% – 15.0%)
FEMALES
White 85.0%
(83.3% – 86.7%)
(N = 2337)
81.0%
(79.2% – 82.8%)
(N = 2451)
4.7%
(3.7% – 5.7%)
Black 76.5%
(68.8% – 84.1%)
(N = 149)
66.7%
(58.8%–74.7%)
(N = 171)
12.7%
(7.1% – 18.3%)
Latina 79.9%
(73.2% – 86.6%)
(N = 185)
73.7%
(66.8% – 80.6%)
(N = 202)
7.8%
(3.9% – 11.7%)
MALES
White 82.1%
(80.2% – 84.0%)
(N = 2236)
73.5%
(71.4% – 75.5%)
(N = 2494)
10.5%
(9.1% – 11.9%)
Black 80.6%
(72.5% – 88.7%)
(N = 124)
69.2%
(60.2% – 78.2%)
(N = 145)
14.2%
(7.2% – 21.1%)
Latino 76.4%
(69.0% – 83.8%)
(N = 166)
63.8%
(56.0% – 71.5%)
(N = 198)
16.6%
(10.4% – 22.8%)
a Based on self-report data from the 2002 Kaiser Permanente Adult Member Health Survey weighted to reflect the age, gender, and geographic 
composition of the membership at the time of the survey.BMC Public Health 2008, 8:227 http://www.biomedcentral.com/1471-2458/8/227
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graduate or equivalent. The logistic regression procedure
in SAS was used to conduct these analyses [15].
To correct for the artificial distribution of vaccinated and
unvaccinated persons within each of the six Race-Ethnic-
ity (nonHispanic White, nonHispanic Black, Hispanic/
Latino) × Gender study groups created by the sampling
design, all study data were weighted to reflect the actual
distribution of self-reported pneumovax status among
study eligibles within each of the groups (see Appendix
for description of how weighting factors were created). All
statistical analyses used these weighted data.
Results
Characteristics of the final White, Black, and Latino study
groups are shown in Table 2. The Black group was fairly
similar to the White group with respect to age and educa-
tion, while the Latino group was younger and less edu-
cated than the White group. Among those with a
documented pneumovax, the length of time between doc-
umented pneumovax date and self-report date was fairly
consistently distributed across all three race-ethnic
groups, with approximately 1/3 having an interval of ≤ 2
years and another 1/3 having an interval of > 2 to 5 years.
However, 12% of the White and Latino male groups had
an interval of greater than 7 years.
The proportion of subjects with documented vaccination
who reported vaccination (sensitivity, or "true positives"),
was significantly lower for Blacks and Latinos than for
Whites; correspondingly, under-reporting of vaccination
(1-sensitivity) was more common among Blacks and Lat-
inos than Whites. The proportion of subjects without doc-
umentation of vaccination who reported being
Table 2: Selected Characteristics of Study Subgroups a
White Black Latino
Characteristics All
(N = 400)
Wtd %
Women
(N= 200)
Wtd %
Men
(N = 200)
Wtd %
All
(N = 300)
Wtd %
Women
(N = 156)
Wtd %
Men
(N = 144)
Wtd %
All
(N = 261)
Wtd %
Women
(N = 131)
Wtd %
Men
(N = 130)
Wtd %
Age
66–69 18.9 19.4 18.4 22.5 24.5 20.0 25.7 32.3 17.8
70–74 29.0 30.2 27.7 31.4 29.1 34.2 31.0 30.4 31.8
75–79 44.1 43.9 44.2 36.9 37.9 35.6 35.6 30.5 41.7
80–85 8.0 6.5 9.7 9.3 8.5 10.2 7.7 6.9 8.7
Education
< 12 years 13.5 12.5 14.5 23.4 21.5 25.6 35.7 34.0 37.7.
High School Grad 27.1 34.7 18.7 24.6 26.9 21.7 23.8 30.8 15.4
Some College 37.0 32.6 41.9 36.5 36.8 36.3 25.5 24.0 27.3
College Grad 22.4 20.3 24.8 15.6 14.8 16.4 15.0 11.3 19.5
High Risk b (Yes) 42.1 32.6 52.8 53.1 47.4 60.1 46.1 40.1 53.4.
Self-reported Pneumococcal 
Vaccination (Yes)
84.3 84.9 83.7 73.5 73.0 74.1 82.4 83.7 80.9
HPMR documented Pneumococcal 
Vaccination (Yes) c
74.8 76.1 73.5 72.1 73.9 69.9 84.0 82.0 86.5.
Interval between HPMR date and 
Self-Report date d
<= 2 yr 34.5 34.8 34.1 33.9 31.6 36.9 35.0 34.9 35.2
> 2–3 yr 12.4 12.9 11.8 17.1 19.4 14.2 14.7 14.2 15.2
> 3–5 yr 29.8 30.7 28.6 28.4 28.0 29.0 27.2 33.1 20.4
> 5–7 yr 14.7 15.8 13.4 13.2 13.5 12.9 13.2 10.1 16.8
> 7–10 yr 7.4 4.7 10.4 5.4 4.9 5.9 8.5 6.8 10.5
> 10 yr 1.3 1.1 1.6 1.9 2.6 1.1 1.4 1.0 1.9
a Results are based on data weighted to reflect actual distribution of self-reported pneumonia vaccination status among all eligible study subjects in 
each race-ethnicity × gender group.
b High Risk = Reported one or more of the following health conditions: diabetes, heart problem, lung/breathing problem (e.g., asthma, COPD), or 
cancer.
c Pneumococcal vaccination date found in Health Plan Medical Record (HPMR) or written note in patient chart about date individual had the 
vaccination outside the Health Plan.
d For people with HPMR documentation of pneumococcal vaccination only.BMC Public Health 2008, 8:227 http://www.biomedcentral.com/1471-2458/8/227
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unvaccinated (specificity or "true negatives") was low,
ranging from 0.415 to 0.56. This finding indicates that
over-reporting (1-specificity) was common. Specificity
was higher for Blacks compared with Latinos and Whites,
but these differences were not statistically significant. PPV,
the proportion of those reporting vaccination who have
documentation of vaccination, did not vary across groups,
but NPV, the proportion of those reporting being unvac-
cinated who have no chart documentation of vaccination,
was lower for Blacks and Latinos than Whites, with the lat-
ter difference being statistically significant (Table 3). The
kappa statistics ranged from .28 for Latinos (fair agree-
ment) to .40 and .42 (just barely moderate agreement) for
Whites and Blacks, respectively (Table 3).
The logistic models revealed no race/ethnic differences for
specificity, but sensitivity was significantly lower among
Blacks and Latinos compared with Whites in models con-
trolling for gender and age and gender, age and education
(Black vs. White: OR = .41, CI: .23–.74; Latino vs. White:
OR = .48, CI: .27–.88, with no appreciable effect of educa-
tion). Gender-specific analyses found these differences to
be statistically significant only among the women.
Comparing estimates based on self-report to Health Plan
medical record data, coverage based on self-report was
substantially higher than coverage based on health plan
records for the White group (84.3% vs. 74.8%), while the
estimates for the Black and Latino groups were more con-
cordant (73.5% vs. 72.1% and 82.4% vs. 84.0%, respec-
tively).
Discussion
This study compared self-report and medical records for a
sample of Black, Latino, and White seniors to examine
whether there are race-ethnic differences in validity of self-
reported pneumococcal vaccination status, and if so, to
explore whether this source of error could help to explain
the persistent race-ethnic disparities in pneumococcal vac-
cination rates observed in national health surveys. We
found that in this sample of Kaiser Permanente health
plan members who met study eligibility requirements, the
Black-White gap in vaccination was substantially less
based on chart documented vaccination compared with
self report. Because this is a highly vaccinated population
in a health care system that stresses the importance of vac-
cination and other clinical preventive services, the esti-
mates of under-reporting (lack of sensitivity) and over-
reporting (lack of specificity) from this study cannot be
directly applied to other populations. Nonetheless, the
findings suggest that differential validity of self-report
may contribute to disparities observed in national self-
reported data.
The balance between under- and over-reporting ulti-
mately determines to what extent true and reported cover-
age differ. In our sample, over-reporting of vaccination
was high in all 3 groups, but vaccinated Blacks and Lati-
nos were less likely to report vaccination than vaccinated
Whites. For Blacks and Latinos, coverage by self-report
and record validation were similar because under- and
over-reporting balanced out. For Whites, however, self-
reported coverage was higher because a lower rate of
under-reporting resulted in inflated rates. The higher rate
Table 3: Measures of Validity and Agreement between Self-Report and Health Plan Medical Records, by Race/Ethnicitya
Group Validity of Self-Reported Measures of Pneumococcal 
Vaccination
Measures of Agreement
Unwtd Ns. Wtd. Ns
SR HPMR SR HPMR Sensitivity
(95% CI)
Specificity
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
Kappa Concordanc
e
Yes No Yes No
White Yes 165 35 Yes 278 59 .931 .419 .826 .671 .395 80.0%
(n = 400) No 66 134 No 21 42 (.918–.942) (.349–.491) (.773–.870) (.609–.728) (.293–.485)
Black Yes 166 34 Yes 183 37 .849 .560 .833 .590 .413 76.7%
(n = 300) No 41 59 No 33 47 (.818–.876) (.479–.637) (.779–.875) (.498–.676) (.296–.520)
Latino Yes 178 22 Yes 191 24 .869 .415 .887 .377 .277 79.8%
(n = 261) No 38 23 No 29 17 (.847–.889) (.307–.532) (.838–.923) (.272–.495) (.133–.419)
a Results are based on data weighted to reflect actual distribution of self-reported pneumonia vaccination status among all eligible study subjects in 
each race-ethnicity × gender group.
SR = Self-report from questionnaire. HPMR = Health Plan medical record documentation of a pneumonia vaccination prior to the date of the self-
report.
Unwtd Ns show 2 × 2 distributions pre-weighting; Wtd N's, rounded to integer form, show the 2 × 2 distributions after post-stratification 
weighting.BMC Public Health 2008, 8:227 http://www.biomedcentral.com/1471-2458/8/227
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of under-reporting of vaccination by Blacks and Latinos
could in part be related to differences in awareness of the
vaccine across groups. For example, in a recent study, eld-
erly Blacks and Latinos were less likely than elderly Whites
to know that pneumococcal vaccination is recommended
for persons their age [8] and in another, elderly Blacks, but
not Latinos, were less likely to be aware of the recommen-
dation [16]. Potential differences in doctor-patient com-
munication also could account for some of the observed
difference [17]. Over-reporting, on the other hand, could
result from confusion with influenza vaccine or an
assumption that pneumococcal vaccination had been
received.
Previous studies of validity of self-report found that over-
all sensitivity of self-report (accuracy of recall about hav-
ing been vaccinated) is generally higher than specificity
(accuracy of recall about not having been vaccinated) [10-
12]. Sensitivity has ranged from 0.75 to 0.97, while specif-
icity has ranged from 0.25 to 0.83. The greater variation in
specificity may largely be a reflection of the variation in
quality of the medical records or in the ability to review
the relevant records. In addition, populations studied var-
ied and may have differed in their propensity to under- or
over-report. It must be noted that race/ethnicity-specific
findings from our study cannot be applied to other popu-
lations as sensitivity and specificity may differ in different
populations, and could even differ in the same popula-
tion over time.
Major strengths of this study include the ability to assess
validity of self-reported vaccination by race/ethnicity and
the thoroughness of the medical record review compared
to previous studies. Measures were taken to improve the
ascertainment of pneumococcal vaccination, i.e. restrict-
ing the study to persons who had been continuous mem-
bers of the health plan from at least age 65 through the
date that the self-report was collected, and searching all of
the individual's health plan medical records for informa-
tion about vaccination status as far as 10 years before the
person turned 65. However, it is unclear how well medical
record documentation serves as a "gold standard" for vac-
cination status. While it can probably be assumed that
documented history of pneumococcal vaccination indi-
cates that the person really was vaccinated, lack of docu-
mentation may not reflect true vaccination status.
Nevertheless, medical record review, while imperfect, has
been the method used to validate self-report in previous
studies [10-12]. It may be more accurate to say that among
those persons with documented vaccination, self-report of
vaccination differed significantly by race/ethnicity, and
while the findings cannot definitively assess the validity of
self report, these differences do suggest that differences in
the validity of self-report by race/ethnicity may exist.
Other limitations include the sample size and the fact that
the study subjects were all members of one health plan
and not representative of the U.S. population. In addition,
the Latinos in the sample were primarily from Mexico and
Central America and needed to be able to complete a
questionnaire in English. Thus, the results for this ethnic
group may not be generalizable to ethnic Hispanics from
Puerto Rico, Cuba, the Caribbean, and other parts of the
Spanish-speaking world, nor to people who cannot read
English.
Self-report is relied on for monitoring progress towards
Healthy People 2010 goals, as well as for HEDIS meas-
ures. Self-reported coverage can be substantially biased or
can be similar to true coverage, depending on the balance
between under and over-reporting. In this study, an
apparent disparity between Blacks and Whites in self-
reported coverage resulted from differences in recall,
while an actual disparity between Whites and Latinos was
obscured by differences in recall. These findings raise the
question whether record-based approaches should be
considered in the health plan setting. However, since
many health systems do not however have systems like
the Kaiser immunization registry, this could be a substan-
tial challenge. In this study, reports of persons who
responded "don't know" were not validated. In the Kaiser
Permanente Member Health Survey, the proportion of
seniors who did not know their pneumococcal vaccina-
tion status was larger than in national surveys such as the
NHIS or BRFSS, possibly as a result of lack of prompting
in a mail survey compared with in-person or telephone
surveys, and Black and Latino seniors were more likely to
fall into this category than White seniors. Validation stud-
ies should be conducted to better understand how those
who respond "don't know" differ, and multiple imputa-
tion methods should be used to quantify potential bias
when a substantial portion of respondents report "don't
know". National and state-level trends are monitored
through self-report in population-based surveys like the
National Health Interview Survey and the Behavioral Risk
Factor Surveillance System. Record-based approaches are
not practical for such surveys. Further studies should,
however, be conducted in population-based settings to
measure validity of self-report across racial/ethnic groups
and within groups over time.
Conclusion
The results of this study suggest that differential self-report
error, i.e., summative effect of over-reporting and under-
reporting within a race-ethnic group, may contribute to
the size and direction of race-ethnic disparities in pneu-
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Appendix
How study weighting factors were created
To correct for the artificial distribution of vaccinated and
unvaccinated persons, all study data were weighted to
reflect the actual distribution of self-reported pneumovax
status among study eligibles in each of 6 Race/Ethnicity ×
Gender study samples. Specifically, for each of 12 study
subgroups (3 Race/Ethnicity × 2 Gender × 2 Self-Reported
Pneumovax Status), weighting factors were created by
dividing the number of study eligibles from that subgroup
by the final number selected for the study sample. The 12
subgroups were then collapsed into 6 Race/Ethnicity ×
Gender groups and the weighted Ns for the two self-
reported pneumovax strata were summed to create a
group weighted N. The resulting 6 samples, after weight-
ing, reflected the underlying distribution of self-reported
pneumovax status among all study eligibles. Finally, we
created a "deflated" weighting factor which resulted in the
sum of weighted Ns in each of the 6 groups equaling the
total sample Ns for these groups, while keeping the same
distribution of self-reported pneumovax status as the
undeflated weighting factor. The "deflated" weighting fac-
tors were used for all analyses.
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